1276:HKEXJiangsu Hengrui Pharmaceuticals Co.,Ltd Analysis

The moving-average structure behind Jiangsu Hengrui Pharmaceuticals Co.,Ltd is bearish at HKD 46.94, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 17.7%. With RSI at 36.7 the momentum picture is approaching oversold, alongside a bearish MACD signal. The recent range runs from support at HKD 45.08 up to resistance at HKD 59.20.
The shares look fair, trading on 34.8 times earnings above a sector average of 30.6. Consensus targets land 68.2% above where the shares trade now. Revenue is growing at 13.0% on a 24.9% profit margin. The 0.42% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 44.4%, a beta of 0.39 and a maximum drawdown of 51.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.